tiprankstipranks
Trending News
More News >
Iovance Biotherapeutics (IOVA)
:IOVA
US Market

Iovance Biotherapeutics (IOVA) Balance Sheet

Compare
3,892 Followers

Iovance Biotherapeutics Balance Sheet

Iovance Biotherapeutics's total assets for Q3 2025 were $904.95M, a decrease of -0.27% from the previous quarter. IOVA total liabilities were $202.66M for the fiscal quarter, a -3.01% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Assets
$ 910.43M$ 780.35M$ 663.98M$ 777.33M$ 768.46M
Total Liabilities
$ 200.02M$ 195.74M$ 164.34M$ 155.67M$ 111.96M
Total Equity Gross Minority
$ 710.40M$ 584.61M$ 499.64M$ 621.66M$ 656.50M
Other Metrics
Currency in USD

Iovance Biotherapeutics Debt to Assets